BDBM446703 US10688093, Compound B50 (U.S. Pat. No.-8,492,377)-(Janssen-Pharma-ceuticals)::US11701353, Compound B50 (U.S. Pat. No. 8,492,377) (Janssen Pharmaceuticals)::benzyl- 21-methoxy-5,7,19- trioxa-2,13,24,26- tetraazapenta- cyclo[18.6.2.03, 11.04,8.023,27]octacosa- 1(26),3(11),4(8),9, 20,22,24,27-octaene- 13-carboxylate

SMILES COc1cc2ncnc3Nc4c5OCOc5ccc4CN(CCCCCOc1cc23)C(=O)OCc1ccccc1

InChI Key InChIKey=RISYBLQATJHOMR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 446703   

TargetTyrosine-protein kinase Fyn(Human)
Pathways Neuro Pharma

US Patent
LigandPNGBDBM446703(US10688093, Compound B50 (U.S. Pat. No.-8,492,377)...)
Affinity DataIC50:  6.69nMAssay Description:The assay procedure determines the IC50 of each potential FYN kinase inhibitor by measuring the enzyme catalyzed ATP-dependent phosphorylation of the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent